ArticleMolecular oncology2021

Circulating tumour DNA is a promising biomarker for risk stratification of central chondrosarcoma with IDH1/2 and GNAS mutations.

Iben Lyskjaer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.